NF-κB signalling is inhibited by glucocorticoid receptor and STAT6 via distinct mechanisms

Journal of Cell Science

Volumn 116, Issue 12, 2003, Pages 2495-2503

  Nelson, Glyn ^a   Wilde, Geraint J C ^a   Spiller, David G ^a   Kennedy, Stephanie M ^a   Ray, David W ^b   Sullivan, Elaine ^c   Unitt, John F ^c   White, Michael R H ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Confocal microscopy; Fluorescent protein fusions; Glucocorticoid receptor; NF B; Signal transduction; STAT6

Indexed keywords

DIMER; GLUCOCORTICOID RECEPTOR; HYBRID PROTEIN; I KAPPA B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; MONOMER; PROTEIN INHIBITOR; STAT6 PROTEIN; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; MIFEPRISTONE; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; STAT6 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; FLUORESCENCE ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STRESS; TIME; TRANSPORT KINETICS; ACTIVE TRANSPORT; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FEEDBACK SYSTEM; GENETICS; HELA CELL; METABOLISM; PHYSIOLOGY; REGULATOR GENE;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL NUCLEUS; FEEDBACK, BIOCHEMICAL; GENES, REGULATOR; HELA CELLS; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-4; MIFEPRISTONE; NF-KAPPA B; RECEPTORS, GLUCOCORTICOID; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; STRESS; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037484097     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.00461     Document Type: Review

References (43)

1. Abu-Amer, Y. (2001). IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-κB. J. Clin. Invest. 107, 1375-1385.
2. Arenzana-Seisdedos, F., Thompson, J., Rodriquez, M. S., Bachelerie, F., Thomas, D. and Hay, R. T. (1995). Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol. Cell. Biol. 15, 2689-2696.
3. Baeuerle, P. A. and Baltimore, D. (1996). NF-κB: ten years after. Cell 87, 13-20.
4. Beck, C. A., Weigel, N. L., Moyer, M. L., Nordeen, S. K. and Edwards, D. P. (1993). The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc. Natl. Acad. Sci. USA 90, 4441-4445.
5. Bennett, B. L., Cruz, R., Lacson, R. G. and Manning, A. M. (1997). Interleukin-4 suppression of tumor necrosis factor α-stimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-κB. J. Biol. Chem. 272, 10212-10219.
6. Birbach, A., Gold, P., Binder, B. R., Hofer, E., de Martin, R. and Schmid, J. A. (2002). Signaling molecules of the NF-κB pathway shuttle constitutively between cytoplasm and nucleus. J. Biol. Chem. 277, 10842-10851.
7. Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M. et al. (2002). Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110, 93-105.
8. Caldenhoven, E., Liden, J., Wissink, S., van de Stolpe, A., Raaijmakers, J., Koenderman, L., Okret, S., Gustafsson, J. A. and van der Saag, P. T. (1995). Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol. Endocrinol. 9, 401-412.
9. Coux, O. and Goldberg, A. L. (1998). Enzymes catalyzing ubiquitination and proteolytic processing of the p105 precursor of nuclear factor κB1. J. Biol. Chem. 273, 8820-8828.
10. DeFranco, D. B., Madan, A. P., Tang, Y. T., Chandran, U. R., Xiao, N. T., Yang, J. (1995). Nucleocytoplasmic shuttling of steroid receptors. Vitam. Horm. Adv. Res. Appl. 51, 315-338.
11. Delphin, S. and Stavnezer, J. (1995). Characterisation of an interleukin-4 (IL-4) responsive region in the immunoglobulin heavy-chain germline E-promoter - regulation by NF-IL-4, a C/EBP family member and NF-κB-p50. J. Exp. Med. 181, 181-192.
12. Doucas, V., Shi, Y., Miyamoto, S., West, A., Verma, I. and Evans, R. M. (2000). Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-κB and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 97, 11893-11898.
13. Galigniana, M. D., Scruggs, J. L., Herrington, J., Welsh, M. J., Carter-Su, C., Housley, P. R. and Pratt, W. B. (1998). Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton. Mol. Endocrinol. 12, 1903-1913.
14. Heck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H. J., Herrlich, P. and Cato, A. C. (1994). A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13, 4087-4095.
15. Heck, S., Bender, K., Kullmann, M., Göttlicher, M., Herrlich, P., Cato, A. C. B. (1997). IκBα-independent downregulation of NF-κB activity by glucocorticoid receptor. EMBO J. 16, 4698-4707.
16. Hollenberg, S. M. and Evans, R. M. (1988). Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55, 899-906.
17. Hong, H., Kohli, K., Garabedian, M. J. and Stallcup, M. R. (1997). GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol. Cell. Biol. 17: 2735-2744.
18. Htun, H., Barsony, J., Renyi, I., Gould, D. L., Hager, G. J. (1996). Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. Proc. Natl. Acad. Sci. USA 93, 4845-4850.
19. McKenna, N. J., Lanz, R. B. and O'Malley, B. W. (1999). Nuclear receptor coregulators: cellular and molecular biology. Endocrine Rev. 20, 321-344.
20. Madan, A. P. and DeFranco, D. B. (1993). Bidirectional transport of glucocorticoid receptors across the nuclear envelope. Proc. Natl. Acad. Sci. USA 90, 3588-3592.
21. Mercurio, F., Zhu, H. Y., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J. W., Young, D. B., Barbosa, M. and Mann, M. (1997). IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278, 860-866.
22. Nelson, G., Paraoan, L., Spiller, D. G., Wilde, G. J. C., Browne, M. A., Djali, P. K., Unitt, J. F., Sullivan, E., Floettmann, E. and White, M. R. H. (2002a). Multi-parameter analysis of the kinetics of NF-κB signalling and transcription in single living cells. J. Cell Sci. 115, 1137-1148.
23. Nelson, G., Wilde, G. J., Spiller, D. G., Sullivan, E., Unitt, J. F. and White, M. R. H. (2002b). Dynamic analysis of STAT6 signalling in living cells. FEBS Lett. 532, 188-192.
24. Nissen, R. M. and Yamamoto, K. R. (2000). The glucocorticoid receptor inhibits NF-κB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 14, 2314-2329.
25. Ohmori, Y. and Hamilton, T. A. (2000). Interleukin-4/STAT6 represses STAT1 and NF-κB-dependent transcription through distinct mechanisms. J. Biol. Chem. 275, 38095-38103.
26. Picard, D. and Yamamoto, K. R. (1987). Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J. 6, 3333-3340.
27. Ray, A. and Prefontaine, K. E. (1994). Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 91, 752-756.
28. Ray, D. W., Suen, C. S., Brass, A., Soden, J. and White, A. (1999). Structure/function of the human glucocorticoid receptor: tyrosine 735 is important for transactivation. Mol. Endocrinol. 13, 1855-1863.
29. Rodriquez, M. S., Thompson, J., Hay, R. T. and Dargemont, C. (1999). Nuclear retention of IκBα protects it from signal-induced degradation and inhibits nuclear factor κB transcriptional activation. J. Biol. Chem. 274, 9108-9115.
30. Schmid, J. A., Birbach, A., Hofer-Warbinek, R., Pengg, M., Burner, U., Furtmuller, P. G., Binder, B. R. and de Martin, R. (2000). Dynamics of NF-κB and IκBα studied with green fluorescent protein (GFP) fusion proteins - investigation of GFP-p65 binding to DNA by fluorescence resonance energy transfer. J. Biol. Chem. 275, 17035-17042.
31. Schmitz, M. L. and Baeuerle, P. A. (1991). The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10, 3805-3817.
32. Schulz, M., Eggert, M., Baniahmad, A., Dostert, A., Heinzel, T. and Renkawitz, R. (2002). RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding. J. Biol. Chem. 277, 26238-26243.
33. Shen, C.-H. and Stavnezer, J. (1998). Interaction of STAT6 and NF-κB: direct association and synergistic activation of Interleukin-4-induced transcription. Mol. Cell. Biol. 18, 3395-3404.
34. Thanos, D. and Maniatis, T. (1995). NF-κB - a lesson in family values. Cell 80, 529-532.
35. Thompson, J. E., Phillips, R. J., Erdjumentbromage, H., Tempst, P. and Ghosh, S. (1995). IκBβ regulates the persistent response in a biphasic activation of NF-κB. Cell 80, 573-582.
36. Wei, S. W., Wang, M. W.-H., Teitelbaum, S. L., Ross, F. P. (2002). Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-κB and mitogen-activated protein kinase signaling. J. Biol. Chem. 277, 6622-6630.
37. White, M. R. H., Morse, J., Boniszewski, Z. A. M., Mundy, C. R., Brady, M. A. W. and Chiswell, D. J. (1990). Imaging of firefly luciferase expression in single mammalian cells using high sensitivity charge-coupled device cameras. Technique 2, 194-201.
38. Whiteside, S. T., Epinat, J. C., Rice, N. R. and Israel, A. (1997). IκB epsilon, a novel member of the IκB family, controls RelA and cRel NF-κB activity. EMBO J. 16, 1413-1426.
39. Yang, J. and DeFranco, D. B. (1996). Assessment of glucocorticoid receptor-heat shock protein 90 interactions in vivo during nucleocytoplasmic trafficking. Mol. Endocrinol. 10, 3-13.
40. Yaron, A., Hatzubai, A., Davis, M., Lavon, I., Amit, S., Manning, A. M., Andersen, J. S., Mann, M., Mercurio, F. and BenNeriah, Y. (1998). Identification of the receptor component of the IκB alpha-ubiquitin ligase. Nature 396, 590-594.
41. Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M. and Karin, M. (1997). The IκB kinase complex (IKK). contains two kinase subunits, IKK alpha and IKK beta, necessary for IκB phosphorylation and NF-κB activation. Cell 91, 243-252.
42. Zandi, E., Chen, Y. and Karin, M. (1998). Direct phosphorylation of I kappa B by IKK alpha and IKK beta: Discrimination between free and NF-kappa B-bound substrate. Science 281, 1360-1363.
43. Zhong, H., SuYang, H., Erdjument-Bromage, H., Tempst, P. and Ghosh, S. (1997). The transcriptional activity of NF-κB is regulated by the IκB associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89, 413-424.